黑料网

Journal of Cellular and Molecular Pharmacology
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review   
  • J Cell Mol Pharmacol 2022, Vol 6(4)Vol 6(4)
  • DOI: 10.4172/jcmp.1000128

New Metabolomic Tools for Studying Cancer Metastasis

Jessalyn M Ubellacker*
Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA
*Corresponding Author : Jessalyn M Ubellacker, Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA, Email: jubellacker@hsphrrd.edu

Received Date: Aug 04, 2022 / Published Date: Aug 29, 2022

Abstract

Ninety percent of cancer deaths are the result of metastasis. The development of robust and sensitive technologies that capture metabolic processes in metastasizing cancer cells has hampered understanding of the role of metabolism during metastasis. We discuss the current technologies for studying I metabolism in primary and metastatic cancer cells, as well as metabolic interactions between cancer cells and the tumour microenvironment (TME) at various stages of the metastatic cascade. We discuss the benefits and drawbacks of each method, as well as how these tools and technologies will help us better understand metastasis [1-15]. Studies using cuttingedge metabolomic technologies to investigate the complex metabolic rewiring of different cells have the potential to reveal novel biological processes and therapeutic interventions for human cancers

Metabolism is essential to all cellular functions because it ultimately drives the generation and utilisation of ATP required for cellular activity. Changes in metabolism can lead to a variety of diseases, including cancer. Cancer cells have the ability to activate and suppress various metabolic pathways. Furthermore, metabolic differences found in cancer cells versus non-cancer cells suggest potential metabolic vulnerabilities that could be therapeutically modulated to slow cancer progression. There has been remarkable progress in understanding the metabolic regulation of cancer cells in recent years, particularly in the context of primary tumour metabolism. However, a thorough understanding of the metabolic regulation of cancer cells during metastasis remains an active area of investigation.

Metastasis is a multifaceted process that includes I uncontrolled proliferation of cancer cells at the primary site, local invasion into surrounding tissue, intravasation into the bloodstream or lymphatics, transportation through circulation, extravasation into distant tissues, and colonisation of secondary organs Because most cancer cells do not survive in these harsh environments, metastasis via this metastatic cascade is a highly inefficient process. However, some cancer cells undergo metabolic adaptations to maximise survival in these harsh environments.

Citation: Ubellacker JM (2022) New Metabolomic Tools for Studying Cancer Metastasis. J Cell Mol Pharmacol 6: 128. Doi: 10.4172/jcmp.1000128

Copyright: © 2022 Ubellacker JM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top